-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on CG Oncology, Raises Price Target to $73

Benzinga·01/21/2026 14:45:58
Listen to the news
RBC Capital analyst Leonid Timashev maintains CG Oncology (NASDAQ:CGON) with a Outperform and raises the price target from $61 to $73.